Levy Howard 4
4 · CATALYST BIOSCIENCES, INC. · Filed Feb 12, 2020
Insider Transaction Report
Form 4
Levy Howard
Chief Medical Officer
Transactions
- Award
Common Stock
2020-02-10$6.23/sh+1,358$8,460→ 1,358 total
Holdings
- 16,094(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the Catalyst Biosciences, Inc. 2018 Employee Stock Purchase Plan ("ESPP") on February 10, 2020.